ARCHIVES

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

This article is from The Cancer Letter archive.

Vol. 34 No. 41 | November 7, 2008

Download PDF Visit The Full Archive

Related Articles

Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older

June 25, 2010

NCI Tells How It Would Spend FY 1978 Research Money

June 25, 1976

Lederle Scientists Report Powerful New Anticancer Agent

July 31, 1987

NCI Cooperative Group Clinical Trials Approved

October 30, 2009

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

FDA to elevate oncology to office level, consolidate most cancer programs. Search planned for oncologist to head new office.

July 23, 2004